Cargando…

Production of Soluble Receptor Activator of Nuclear Factor Kappa-Β Ligand and Osteoprotegerin by Apical Periodontitis Cells in Culture and Their Modulation by Cytokines

RANKL, a bone-destructive cytokine, and OPG, its osteoprotective counterpart, are expressed in periapical lesions (PLs), which represent hystopatological manifestations of apical periodontitis. However, their regulation in PLs has not been elucidated yet. Therefore, our aim was to study the producti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duka, Miloš, Eraković, Mile, Dolićanin, Zana, Stefanović, Dara, Čolić, Miodrag
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442274/ https://www.ncbi.nlm.nih.gov/pubmed/31011287 http://dx.doi.org/10.1155/2019/8325380

Ejemplares similares

Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health
por: Tabari, Zahra Alizadeh, et al.
Publicado: (2013)

Mesenchymal Stromal Cells from Healthy and Inflamed Human Gingiva Respond Differently to Porphyromonas gingivalis
por: Bekić, Marina, et al.
Publicado: (2022)

Effect of Breastfeeding on Serum Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-Kappa B Ligand in Full Term Neonates
por: Rafeey, Mandana, et al.
Publicado: (2013)

Receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in gingival crevicular fluid
por: Sarlati, Fatemeh, et al.
Publicado: (2012)

Effects of High and Low Doses of Folic Acid on the Soluble Receptor Activator of Nuclear Factor-kappa B Ligand/Osteoprotegerin Ratio during Pregnancy
por: FATHI MAROUFI, Nazila, et al.
Publicado: (2017)

Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease
por: Pacifico, Lucia, et al.
Publicado: (2018)

Roles of osteoprotegerin in endocrine and metabolic disorders through receptor activator of nuclear factor kappa-B ligand/receptor activator of nuclear factor kappa-B signaling
por: Zhang, Luodan, et al.
Publicado: (2022)

Osteoprotegerin/receptor activator of nuclear factor-κB ligand are involved in periodontitis-promoted vascular calcification
por: Jiao, Mengyu, et al.
Publicado: (2022)

Osteoprotegerin/Receptor Activator of Nuclear Factor-Kappa B Ligand/Receptor Activator of Nuclear Factor-Kappa B Axis in Obesity, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease
por: Vachliotis, Ilias D., et al.
Publicado: (2023)

Pomegranate Peel Extract Differently Modulates Gene Expression in Gingiva-Derived Mesenchymal Stromal Cells under Physiological and Inflammatory Conditions
por: Čolić, Miodrag, et al.
Publicado: (2023)

Isoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells
por: Lee, Sun Kyoung, et al.
Publicado: (2015)

Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients
por: Carmona-Fernandes, Diana, et al.
Publicado: (2011)

Expression of osteoprotegerin and osteoprotegerin ligand in giant cell tumor of bone and its clinical significance
por: YU, XIUCHUN, et al.
Publicado: (2013)

Loading history changes the morphology and compressive force-induced expression of receptor activator of nuclear factor kappa B ligand/osteoprotegerin in MLO-Y4 osteocytes
por: Wang, Ziyi, et al.
Publicado: (2020)

Proinflammatory Cytokine Expression in Apical Periodontitis from Diabetic Patients
por: Borgo Sarmento, Estéfano, et al.
Publicado: (2023)

Are comorbidities associated with the cytokine/chemokine profile of persistent apical periodontitis?
por: Agger, Anne Eriksson, et al.
Publicado: (2023)

The Role of Osteoprotegerin and Its Ligands in Vascular Function
por: Rochette, Luc, et al.
Publicado: (2019)

Unintentional Fall-Related Mortality among the Elderly in Serbia: Importance of Death Reporting Quality
por: Lazarevic, Konstansa, et al.
Publicado: (2022)

Osteoprotegerin, Soluble Receptor Activator of Nuclear Factor-κB Ligand, and Subclinical Atherosclerosis in Children and Adolescents with Type 1 Diabetes Mellitus
por: Lambrinoudaki, Irene, et al.
Publicado: (2013)

Association of salivary RANKL and osteoprotegerin levels with periodontal health
por: Ochanji, A. A., et al.
Publicado: (2017)

Impact of the Rapid Normalization of Chronic Hyperglycemia on the Receptor Activator of Nuclear Factor-Kappa B Ligand and the Osteoprotegerin System in Patients Living with Type 2 Diabetes: RANKL-GLYC Study
por: Dardari, Dured, et al.
Publicado: (2022)

The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature Osteoclasts
por: Burgess, Teresa L., et al.
Publicado: (1999)

Soluble TRAIL does not impair the anti-osteoclastic activity of osteoprotegerin
por: Zauli, Giorgio, et al.
Publicado: (2008)

Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells
por: Su, Fang, et al.
Publicado: (2015)

PD35 - In vitro effects of atorvastatin on function, proliferation and cytokine production of human peripheral blood mononuclear cells
por: Turuntas, Vladimir, et al.
Publicado: (2014)

Pro-inflammatory and anti-inflammatory cytokine expression in post-treatment apical periodontitis
por: Dessaune, Nilton, et al.
Publicado: (2018)

Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines
por: Labovsky, Vivian, et al.
Publicado: (2012)

Corneal Stem Cells as a Source of Regenerative Cell-Based Therapy
por: Nurković, Jasmin S., et al.
Publicado: (2020)

Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
por: Park, Hye-Rim, et al.
Publicado: (2003)

Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2016)

Pro- and Antiapoptotic Markers in Upper Tract Urothelial Carcinoma Associated with Balkan Endemic Nephropathy
por: Jankovic-Velickovic, Ljubinka, et al.
Publicado: (2011)

In Rats, Whole and Refined Grains Decrease Bone Mineral Density and Content through Modulating Osteoprotegerin and Receptor Activator of Nuclear Factor Kappa B
por: Sakr, Hussein, et al.
Publicado: (2023)

Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss
por: Trouvin, Anne-Priscille, et al.
Publicado: (2010)

Microbiota in the apical root canal system of tooth with apical periodontitis
por: Qian, Wenhao, et al.
Publicado: (2019)

Effect of Periodontal Surgery on Osteoprotegerin Levels in Gingival Crevicular Fluid, Saliva, and Gingival Tissues of Chronic Periodontitis Patients
por: Hassan, Sandy H. S., et al.
Publicado: (2015)

Serum, saliva, and GCF concentration of RANKL and osteoprotegerin in smokers versus nonsmokers with chronic periodontitis
por: Behfarnia, Parichehr, et al.
Publicado: (2016)

Bone sparing effect of osteoprotegerin and anti-inflammatory cytokines in collagen-induced arthritis
por: de Vernejoul, M, et al.
Publicado: (2003)

Platelet-rich fibrin increases the osteoprotegerin/receptor activator of nuclear factor-κB ligand ratio in osteoblasts
por: Sumida, Ryuta, et al.
Publicado: (2019)

Periodontitis apical aguda y crónica. /
por: Orta Castañeda, Clara Velia
Publicado: (1995)

Apical periodontitis after intense bruxism
por: Gund, Madline P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6cqmrctkv6db2ce1q9cjt0b27h